|
1
|
Machlowska J, Baj J, Sitarz M, Maciejewski
R and Sitarz R: Gastric cancer: Epidemiology, risk factors,
classification, genomic characteristics and treatment strategies.
Int J Mol Sci. 21(4012)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang H, Guo W, Hu Y, Mou T, Zhao L, Chen
H, Lin T, Li T, Yu J, Liu H and Li G: Superiority of the 8th
edition of the TNM staging system for predicting overall survival
in gastric cancer: Comparative analysis of the 7th and 8th editions
in a monoinstitutional cohort. Mol Clin Oncol. 9:423–431.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Feng F, Liu J, Wang F, Zheng G, Wang Q,
Liu S, Xu G, Guo M, Lian X and Zhang H: Prognostic value of
differentiation status in gastric cancer. BMC Cancer.
18(865)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhao B, Mei D, Lv W, Lu H, Bao S, Lin J
and Huang B: Clinicopathologic features, survival outcome, and
prognostic factors in gastric cancer patients 18-40 years of age. J
Adolesc Young Adult Oncol. 9:514–521. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Desjardins M, Arjunaraja S, Stinson JR,
Dorjbal B, Sundaresan J, Niemela J, Raffeld M, Matthews HF, Wang A,
Angelus P, et al: A Unique heterozygous CARD11 mutation combines
pathogenic features of both gain- and loss-of-function patients in
a four-generation family. Front Immunol. 9(2944)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Juilland M and Thome M: Holding all the
CARDs: How MALT1 controls CARMA/CARD-dependent signaling. Front
Immunol. 9(1927)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jattani RP, Tritapoe JM and Pomerantz JL:
Cooperative control of caspase recruitment domain-containing
protein 11 (CARD11) signaling by an unusual array of redundant
repressive elements. J Biol Chem. 291:8324–8336. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kou Z, Mao M, Liu H, Wang X, Wang Z, Gu Z,
Lang T, Nie Y, Wang Y, Huang Q, et al: CARD11 is a novel target of
miR-181b that is upregulated in chronic lymphocytic leukemia.
Biomark Med. 15:623–635. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhu L, Guo Q, Lu X, Zhao J, Shi J, Wang Z
and Zhou X: CTD-2020K17.1, a novel long non-coding RNA, promotes
migration, invasion, and proliferation of serous ovarian cancer
cells in vitro. Med Sci Monit. 24:1329–1339. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Watt SA, Purdie KJ, den Breems NY, Dimon
M, Arron ST, McHugh AT, Xue DJ, Dayal JH, Proby CM, Harwood CA, et
al: Novel CARD11 mutations in human cutaneous squamous cell
carcinoma lead to aberrant NF-κB regulation. Am J Pathol.
185:2354–2363. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cheng Z, Liu G, Huang C and Zhao X: KLF5
activates lncRNA DANCR and inhibits cancer cell autophagy
accelerating gastric cancer progression. NPJ Genom Med.
6(75)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen W, Zhang J, Fu H, Hou X, Su Q, He Y
and Yang D: KLF5 is activated by gene amplification in gastric
cancer and is essential for gastric cell proliferation. Cells.
10(1002)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ramadas RA, Roche MI, Moon JJ, Ludwig T,
Xavier RJ and Medoff BD: CARMA1 is necessary for optimal T cell
responses in a murine model of allergic asthma. J Immunol.
187:6197–6207. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bertin J, Wang L, Guo Y, Jacobson MD,
Poyet JL, Srinivasula SM, Merriam S, DiStefano PS and Alnemri ES:
CARD11 and CARD14 are novel caspase recruitment domain
(CARD)/membrane-associated guanylate kinase (MAGUK) family members
that interact with BCL10 and activate NF-kappa B. J Biol Chem.
276:11877–11882. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
McAllister-Lucas LM, Jin X, Gu S, Siu K,
McDonnell S, Ruland J, Delekta PC, Van Beek M and Lucas PC: The
CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent
vascular inflammation and atherogenesis. J Biol Chem.
285:25880–25884. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang S, Li Y, Hu YH, Song R, Gao Y, Liu
HY, Shu HB and Liu Y: STUB1 is essential for T-cell activation by
ubiquitinating CARMA1. Eur J Immunol. 43:1034–1041. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Park Y, Jin HS and Liu YC: Regulation of T
cell function by the ubiquitin-specific protease USP9X via
modulating the Carma1-Bcl10-Malt1 complex. Proc Natl Acad Sci USA.
110:9433–9438. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Qu C, Liu Y, Kunkalla K, Singh RR, Blonska
M, Lin X, Agarwal NK and Vega F: Trimeric G protein-CARMA1 axis
links smoothened, the hedgehog receptor transducer, to NF-κB
activation in diffuse large B-cell lymphoma. Blood. 121:4718–4728.
2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Blonska M and Lin X: CARMA1-mediated
NF-kappaB and JNK activation in lymphocytes. Immunol Rev.
228:199–211. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shi X, Xia S, Chu Y, Yang N, Zheng J, Chen
Q, Fen Z, Jiang Y, Fang S and Lin J: CARD11 is a prognostic
biomarker and correlated with immune infiltrates in uveal melanoma.
PLoS One. 16(e0255293)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen L, Yang QC, Li YC, Yang LL, Liu JF,
Li H, Xiao Y, Bu LL, Zhang WF and Sun ZJ: Targeting CMTM6
suppresses stem cell-like properties and enhances antitumor
immunity in head and neck squamous cell carcinoma. Cancer Immunol
Res. 8:179–191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hung JJ, Kao YS, Huang CH and Hsu WH:
Overexpression of Aiolos promotes epithelial-mesenchymal transition
and cancer stem cell-like properties in lung cancer cells. Sci Rep.
9(2991)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Deng L, Zou J, Su Y, Wang M and Zhao L:
Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells
through Hippo-YAP signaling pathway. Clin Transl Oncol.
24:2210–2221. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Odero-Marah V, Hawsawi O, Henderson V and
Sweeney J: Epithelial-mesenchymal transition (EMT) and prostate
cancer. Adv Exp Med Biol. 1095:101–110. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dong D, Na L, Zhou K, Wang Z, Sun Y, Zheng
Q, Gao J, Zhao C and Wang W: FZD5 prevents epithelial-mesenchymal
transition in gastric cancer. Cell Commun Signal.
19(21)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gao Y, Ding Y, Chen H, Chen H and Zhou J:
Targeting Krüppel-like factor 5 (KLF5) for cancer therapy. Curr Top
Med Chem. 15:699–713. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Marrero-Rodríguez D, la Cruz HA,
Taniguchi-Ponciano K, Gomez-Virgilio L, Huerta-Padilla V,
Ponce-Navarrete G, Andonegui-Elguera S, Jimenez-Vega F,
Romero-Morelos P, Rodriguez-Esquivel M, et al: Krüppel like factors
family expression in cervical cancer cells. Arch Med Res.
48:314–322. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hart GT, Hogquist KA and Jameson SC:
Krüppel-like factors in lymphocyte biology. J Immunol. 188:521–526.
2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen P, Qian XK, Zhang YF, Sun XG, Shi XJ
and Gao YS: KLF5 promotes proliferation in gastric cancer via
regulating p21 and CDK4. Eur Rev Med Pharmacol Sci. 24:4224–4231.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhou Y, Xu Q, Shang J, Lu L and Chen G:
Crocin inhibits the migration, invasion, and epithelial-mesenchymal
transition of gastric cancer cells via miR-320/KLF5/HIF-1α
signaling. J Cell Physiol. 234:17876–17885. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chia NY, Deng N, Das K, Huang D, Hu L, Zhu
Y, Lim KH, Lee MH, Wu J, Sam XX, et al: Regulatory crosstalk
between lineage-survival oncogenes KLF5, GATA4 and GATA6
cooperatively promotes gastric cancer development. Gut. 64:707–719.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Juilland M and Thome M: Role of the
CARMA1/BCL10/MALT1 complex in lymphoid malignancies. Curr Opin
Hematol. 23:402–409. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lork M, Staal J and Beyaert R:
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1
signalosome in T cells. Cell Immunol. 340(103877)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Roche MI, Ramadas RA and Medoff BD: The
role of CARMA1 in T cells. Crit Rev Immunol. 33:219–243.
2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gross O, Grupp C, Steinberg C, Zimmermann
S, Strasser D, Hannesschläger N, Reindl W, Jonsson H, Huo H,
Littman DR, et al: Multiple ITAM-coupled NK-cell receptors engage
the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK
activation to selectively control cytokine production. Blood.
112:2421–2428. 2008.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wegener E and Krappmann D:
CARD-Bcl10-Malt1 signalosomes: Missing link to NF-kappaB. Sci STKE.
2007(pe21)2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wegener E, Oeckinghaus A, Papadopoulou N,
Lavitas L, Schmidt-Supprian M, Ferch U, Mak TW, Ruland J,
Heissmeyer V and Krappmann D: Essential role for IkappaB kinase
beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell
activation. Mol Cell. 23:13–23. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sun D, Toan X, Zhang Y, Chen Y, Lu R, Wang
X and Fang J: Mammalian target of rapamycin pathway inhibition
enhances the effects of 5-aza-dC on suppressing cell proliferation
in human gastric cancer cell lines. Sci China C Life Sci.
51:640–647. 2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lang SA, Gaumann A, Koehl GE, Seidel U,
Bataille F, Klein D, Ellis LM, Bolder U, Hofstaedter F, Schlitt HJ,
et al: Mammalian target of rapamycin is activated in human gastric
cancer and serves as a target for therapy in an experimental model.
Int J Cancer. 120:1803–1810. 2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Xu DZ, Xia LP, Lin TY, Cai MY, Fan XJ,
Zhan YQ, Zhou ZW and Li W: Expression and clinical significance of
p-mTOR in gastric cancer. J Sun Yat-Sen Univ (Med Sci). 30:304–307.
2009.
|
